Literature DB >> 27655462

What's Old is New Again: Fresh Hope for Treatment Refractory Hypersomnolence Patients.

Nathaniel F Watson1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27655462      PMCID： PMC5033732          DOI： 10.5664/jcsm.6178

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  6 in total

Review 1.  Pharmacology of flumazenil.

Authors:  J G Whitwam; R Amrein
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1995

2.  Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.

Authors: 
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

3.  Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial.

Authors:  Lynn Marie Trotti; Prabhjyot Saini; Donald L Bliwise; Amanda A Freeman; Andrew Jenkins; David B Rye
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

4.  Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients.

Authors:  Lynn Marie Trotti; Prabhjyot Saini; Catherine Koola; Vincent LaBarbera; Donald L Bliwise; David B Rye
Journal:  J Clin Sleep Med       Date:  2016-10-15       Impact factor: 4.062

5.  Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors.

Authors:  David B Rye; Donald L Bliwise; Kathy Parker; Lynn Marie Trotti; Prabhjyot Saini; Jacqueline Fairley; Amanda Freeman; Paul S Garcia; Michael J Owens; James C Ritchie; Andrew Jenkins
Journal:  Sci Transl Med       Date:  2012-11-21       Impact factor: 17.956

6.  Three-minute critical appraisal of a case series article.

Authors:  Kevin Chan; Mohit Bhandari
Journal:  Indian J Orthop       Date:  2011-03       Impact factor: 1.251
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.